Ryan Lu Email & Phone Number

Taipei City, Taiwan

OPDIVO & Zeposia

• Praluent
• Developed and executed a launch plan for a new dosage of Praluent to defend new market entrant, now on track to obtain TFDA approval, by closely collaborating with Medical, Regulatory Affairs, Supply Chain.
• Developed a comprehensive business case, including patient forecast modeling, brand and marketing strategies, market access strategy, customer and patient journey development, and listing strategy.
• Expand reimbursement criteria with market access team to enhance accessibility, by conducting budget impact analysis and developing engagement plan for key medical societies and reimbursement experts.
• Differentiate Praluent from competing drug by emphasizing Praluent’s strength in maintaining a consistently low LDL-C level, shaping HCPs’ belief to limit competing drug from entering our key market, through a series.
• Cultivated tier-1 brand advocates through an advocacy plan, by collaborating with the sales team to deliver atailor-made engagement approach for individual KOL and push them up the adoption ladder.

• Plavix & Multaq
• Led 20% increase in Plavix prescription by optimizing stroke treatment pathway at 4 medical centers after strategically collaborating with KOLs to overcome initial strong resistance.
• Collaborated with medical societies to include Plavix and aspirin dual therapy in the hospital accreditation, foreseeing a 10% increase in adoption rate nationally and a $100M sales growth in 2025.
• Developed an OCE plan for Plavix and Multaq with Agile practices, generating valuable insights for digital-first selling model, leading to successful OCE cases, and winning the Annual OCE Star Award.

Taipei City, Taiwan

• Achieved a remarkable 68% growth for Soliqua and 3% for Toujeo in 2022 Q2-Q3 by initiating a successful Continuous Glucose Monitor Program at Landseed International Hospital.
• Recognized as top sales and OCE star at Sanofi HK/TW in 2021 and successfully listed core products at several accounts, including Soliqua, Multaq, and Targocid.

Taipei City, Taiwan

• Responsible for RH/AH Accounts under MOHW, Military, and VGH system in Taipei, Yilan, and Hualien.
• Top as Gold Card Holder(Top Sales) in 2021
• Recognized as Omni-Channel Engagement Star at Sanofi HKTW in 2021
• In 2021, Each product in responsible territory showed strong growth performance even under COVID-19 severe impact. Plavix:+20.8%, Multaq+62.3%, Soliqua+39.3%, and Toujeo+6.5%.
• Successfully listed Soliqua/Multaq@MOHW-TPE, Soliqua@MOHW-Hualien, Multaq@Military-Hualien, and Soliqua/Targocid@VGH-Fenglin.
• Probing/Objection Handling Experience Sharing and market intelligence discussion with Team Colleague on and off the team meeting

• A 3-month contract Job before Mandatory Military Service
• Successfully help 1500+ merchants in Taiwan to enjoy LINE Pay service
• Weekly coordinate with iPass on merchants registration issues during the system transition
• As supporting team in BD Function, maintaining relation with merchants and providing merchants behavior report for leadership team better coming out future action plan.

Taipei City

• Assist Account Executive on over 10+ Visa’s event planning and coordination, ex. Media roundtable, 2019 Team Visa Press Conference, Visa Volunteering Day, and 2020 CTBC-China Airlines PartnershipPress Conference.
• Monthly update/analyze policies and stakeholders news in Taiwan Fintech Industry.
• In charge of Visa PR Coverage Report, Monthly Report, and QAR Report, and optimize the reportcontent.
• Analyzing NR share of voice report data to better providing AM a clear view on market.

Taipei City

• In charge of corporate news release editing, 50+ NR were produced, covering from corporatecomm., external affairs to collaborations with stakeholders
• Coordinate 10+ company-wised events, ex. Town Hall, Annual Conference, Year-End Party,Global Officer Visit, and MSD for Mothers Program(CSR)
• Editing 3-week-long communication letter and events planning during the corporate transitionperiod, aiming to deepen employees’ understand on leadership team decision and the concept of agility

Bachelor Of Social Science, Political Science Major / Japanese Minor, 3.9/4.0

Exchange Program